0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

The Role of Antineutrophil Cytoplasmic Antibody (c-ANCA) Testing in the Diagnosis of Wegener Granulomatosis: A Literature Review and Meta-analysis

Jaya K. Rao, MD; Morris Weinberger, PhD; Eugene Z. Oddone, MD; Nancy B. Allen, MD; Pamela Landsman, MPH; and John R. Feussner, MD
[+] Article and Author Information

From Durham Veterans Affairs Medical Center and Duke University Medical Center, Durham, North Carolina; and Roudebush Veterans Affairs Medical Center and Indiana University Medical Center, Indianapolis, Indiana. Acknowledgments: The authors thank Gregory Samsa, PhD, and Victor Hasselbad, PhD, for helpful advice; and Theodore Pincus, MD, for his constructive review of earlier drafts of this manuscript. Grant Support: Dr. Rao was supported by the Health Services Research Field Program, Department of Veterans Affairs, and the Department of Veterans Affairs Fellowship Program in Health Services Research. Drs. Oddone and Weinberger are supported by the Department of Veterans Affairs Health Services Research Career Development Program. Requests for Reprints: Dr. Jaya Rao, Health Services Research and Development (11H), Roudebush Veterans Affairs Medical Center, 1481 West 10th Street, Indianapolis, IN 46202. Current Author Addresses: Drs. Rao and Weinberger: Health Services Research & Development (11H), Roudebush Veterans Affairs Medical Center, 1481 West 10th Street, Indianapolis, IN 46202. Drs. Oddone and Feussner: Health Services Research & Development (152), Durham Veterans Affairs Medical Center, 508 Fulton Street, Durham, NC 27705. Dr. Allen: Division of Rheumatology, Box 3440, Duke University Medical Center, Durham, NC 27710. Ms. Landsman: Pfizer, Inc., 219-2-3, 235 East 42nd Street, New York, NY 10017-5755.


Copyright ©2004 by the American College of Physicians


Ann Intern Med. 1995;123(12):925-932. doi:10.7326/0003-4819-123-12-199512150-00005
Text Size: A A A

Purpose: To summarize the literature on the clinical utility of antineutrophil cytoplasmic antibody (c-ANCA) as a diagnostic marker for Wegener granulomatosis.

Data Sources: A structured literature search was done using MEDLINE; this search, combined with a manual search, yielded 747 articles for potential inclusion. These articles passed through a 4-stage review. Studies were included if they had a specified reference standard and a systematic method of patient selection and if a 2 × 2 contingency table could be constructed from their results. Fifteen articles met these criteria.

Data Extraction: 3 physicians reviewed all selected articles. Detailed data abstraction was done, and the quality of the study methods was assessed. Items abstracted included the method of patient selection, the study design, the reference standard, the c-ANCA testing technique, disease activity, and the test results. Disagreements among reviewers were resolved by consensus. Contingency tables were used to calculate the operating characteristics for Wegener granulomatosis overall and for active and inactive Wegener granulomatosis.

Results: The sensitivities of c-ANCA testing for overall Wegener granulomatosis ranged from 34% to 92%, and the specificities ranged from 88% to 100%. The pooled sensitivity was 66% (95% CI, 57% to 74%), and the pooled specificity was 98% (CI, 96% to 99.5%). Four articles provided data on disease activity. For active disease, the pooled sensitivity was 91% (CI, 87% to 95%), and the pooled specificity was 99% (CI, 97% to 99.9%). For inactive disease, the pooled sensitivity and specificity were 63% and 99.5%, respectively.

Conclusions: Although c-ANCA test results may serve clinicians as adjunct evidence for the diagnosis of Wegener granulomatosis, these results must be viewed in the context of the patient's clinical picture and disease activity and the prevalence of Wegener granulomatosis in the clinical setting in which the patient is seen.

Figures

Grahic Jump Location
Figure 1.
Operating characteristics of c-ANCA testing for confirmed Wegener granulomatosis.Top.Middle.Bottom.

Overall disease. Active disease. Inactive disease.

Grahic Jump Location

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Topic Collections
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)